Investment Thesis
Invesco is experiencing severe operational distress with negative net income of -$726.3M despite 5.1% revenue growth, indicating structural profitability challenges in its investment advisory business. While strong free cash flow generation ($1.4B) and healthy liquidity ratios provide near-term financial stability, the company's negative operating margins (-10.9%), deteriorating ROE (-5.9%), and worsening year-over-year profitability decline (-315.5%) signal fundamental business challenges that require significant operational restructuring.
IVZ Strengths
- Strong free cash flow generation of $1.4B with 22.6% FCF margin demonstrates underlying cash generation capability despite losses
- Healthy liquidity position with current ratio of 1.46x and $1.0B cash equivalents provides financial flexibility
- Conservative leverage with debt-to-equity ratio of 0.15x limits financial distress risk and refinancing concerns
- Revenue growth of 5.1% YoY shows market activity and client assets under management are still growing
IVZ Risks
- Severe operating losses of -$695.7M with -10.9% operating margin indicate core business is unprofitable on operational basis
- Net income deterioration of -315.5% YoY with negative ROE of -5.9% shows management is destroying shareholder value
- Negative interest coverage of -21.6x means the company cannot cover interest expenses from operating income, raising sustainability concerns
- Investment advisory sector faces headwinds from fee compression and shift to passive investing, creating secular margin pressure
- Significant insider stock activity (18 Form 4 filings) warrants monitoring for potential insider selling or hedging signals
Key Metrics to Watch
- Operating income and operating margin recovery trajectory - critical to return to profitability
- Assets under management (AUM) and organic growth rates - validates revenue sustainability
- Net revenue yield and fee compression trends - determines pricing power and margin recovery potential
- Restructuring progress and cost reduction initiatives - essential for operational breakeven
- Return to positive GAAP net income - necessary condition for investment viability
IVZ Financial Metrics
IVZ Profitability Ratios
IVZ Balance Sheet & Liquidity
IVZ 5-Year Financial Trend
5-Year Trend Summary: Invesco Ltd.'s revenue has remained relatively flat over the 5-year period, with a 8% decline. The most recent EPS of $-0.73 indicates the company is currently unprofitable.
IVZ Growth Metrics (YoY)
IVZ Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.5B | N/A | $0.12 |
| Q2 2025 | $1.5B | N/A | $-0.03 |
| Q1 2025 | $1.5B | $141.5M | $0.31 |
| Q3 2024 | $1.4B | $55.0M | $0.12 |
| Q2 2024 | $1.4B | $132.2M | $0.29 |
| Q1 2024 | $1.4B | $141.5M | $0.31 |
| Q3 2023 | $1.4B | $131.4M | $0.29 |
| Q2 2023 | $1.4B | $121.0M | $0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
IVZ Capital Allocation
IVZ SEC Filings
Access official SEC EDGAR filings for Invesco Ltd. (CIK: 0000914208)